The CRS-7 generates an extremely narrow coherent radiation beam — a focused column of X-ray band energy approximately 0.3 millimetres in diameter that maintains coherence over short distances before diffraction limits its effectiveness. At this scale and intensity, the beam does not burn or cauterise in the manner of conventional laser weapons; instead, it severs material at the molecular level with near-zero thermal spread. The cut is so precise that biological tissue on either side of the beam path is essentially undamaged — the wound is a clean incision, not a burn channel. This characteristic gives the weapon its name and its disturbing dual-use reputation.

The weapon's operating principle derives directly from surgical radiation technology — specifically, the coherent X-ray scalpels used in precision neurosurgery and microsurgical robotics. LAZARUS PHARMACEUTICALS developed the CRS-7 as a licensed derivative of their surgical suite technology, initially marketed to corporate medical teams for field surgical applications. The tactical application was noted almost immediately: a weapon that could sever tendons, nerves, or blood vessels with surgical precision, leaving no visible external wound until the target moved and the incision opened, represented a unique capability profile.

The CRS-7's practical limitations are significant: effective range is 3–8 metres, the beam width requires precise targeting (the weapon integrates a targeting assist system, but moving targets at range are challenging), and the power draw limits sustained operation. It is not a weapon for firefights. It is a weapon for situations where a firefight has already been decided and the question is only how much damage to do and where. Its presence in GLMZ's underworld is small but consistent — it surfaces wherever someone needs work done that looks like an accident or a medical complication.